FDA approves new combination treatment for acute myeloid leukemia

[ad_1]

The U.S. Food and Drug Administration has approved Rydapt (midostaurin) for the treatment of adult patients with newly diagnosed acute myeloid leukemia (AML) who have a specific genetic mutation…

[ad_2]

Source link

sticket2

Would you like to get the test?